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Although protective immunity in C57BL/6 mice induced by a single dose of the radiation-attenuated
schistosome vaccine is believed to be mediated by Th1-type immune responses, we here report that in BALB/c
mice protection can also depend upon signaling via the interleukin-4 (IL-4) receptor which conventionally
governs the development of Th2-type immune responses. We show that in BALB/c mice deficient for the IL-4
receptor a chain (IL-4Ra2/2), which are unresponsive to IL-4 and IL-13, vaccine-induced protection is
abrogated compared with that in wild-type (WT) mice. In vaccinated IL-4Ra2/2 mice, IL-12p40 production by
cells from the skin exposure site was elevated, although gamma interferon (IFN-g) production in draining
lymphoid tissues was similar in WT and IL-4Ra2/2 mice. Nevertheless, the effector response in IL-4Ra2/2
mice was Th1 biased with elevated IFN-g in the lungs and higher immunoglobulin G2a (IgG2a) and IgG2b
titers but negligible quantities of Th2-associated IgG1 and IgE. Interestingly, levels of IL-4 were equivalent in
WT and IL-4Ra2/2 mice, indicating that Th2 responses were not dependent upon signaling by IL-4 or IL-13.
No differences in the phenotype and composition of the pulmonary effector mechanism that might explain the
failure to induce protection in IL-4Ra2/2 mice were detected. However, passive transfer of partial protection
to naive IL-4Ra2/2 mice, using serum from vaccinated WT mice, indicates that Th2-associated antibodies such
as IgG1 have a role in parasite elimination in BALB/c strain mice and that signaling via IL-4R can be an
important factor in the generation of protection.
The balance of Th1- and Th2-type lymphocyte populations
in the host after exposure to infectious agents is crucial to the
development of protective immunity or immunopathology. In
turn, the differentiation of these polarized lymphocyte popu-
lations depends to a great extent upon the relative abundance
of various cytokines (e.g., interleukin-12 [IL-12] and IL-4) dur-
ing the priming of the antigen-specific lymphocyte population
by antigen-presenting cells (reviewed in references 52 and 56).
While IL-12 and IL-4 are key promoters of Th1 and Th2 cell
populations, respectively, they are also mutually antagonistic,
with IL-4 capable of inhibiting the expression of the b2 subunit
of the IL-12 receptor (62) and IL-12 being responsible for the
suppression of IL-4 production in a gamma interferon (IFN-
g)-dependent manner (42).
In the context of protective immunity, we recently demon-
strated that the high level of Th1-mediated protection (60 to
70%) induced in C57BL/6 mice by the radiation-attenuated
(RA) vaccine model of murine schistosomiasis is dependent
upon the presence of endogenous IL-12 (1, 46). Moreover,
administration of exogenous recombinant IL-12 during the
first few days after vaccination leads to elevated levels of pro-
tection, concurrent with increased levels of Th1-associated hu-
moral and cell-mediated immune responses (1, 65, 66). Nev-
ertheless, even in the absence of Th1-type responses (i.e., in
vaccinated IL-12p402/2 mice), a reduction in worm burdens of
between 35 and 45% was observed, suggesting that Th2-type
responses may also have a role in protection in this model (1,
3). Since IL-4 is a major factor in the differentiation of Th2-
type cells (24) and, like IL-12, is produced by different cell
types of the innate immune response, it is possible that this
cytokine contributes to the induction of protective immunity in
the RA vaccine model.
Previous studies of the role of IL-4 showed that protective
immunity to Schistosoma mansoni was not affected by the in
vivo administration of anti-IL-4 monoclonal antibody (MAb) 2
to 3 weeks postvaccination and throughout the period of chal-
lenge infection, despite a significant reduction in the levels of
IL-5 and immunoglobulin E (IgE) (57). However, this study
did not address the question of whether IL-4 was important
during the induction process in the first 2 weeks after vaccina-
tion. Nevertheless, there was also no significant reduction in
the levels of protection induced in IL-42/2 mice following
exposure to three doses of irradiated cercariae (29), demon-
strating that IL-4 was not an important component of immu-
nity to schistosomes. This was verified recently by Hoffmann et
al. (23), who showed that protection in IL-42/2 mice exposed
to one dose of irradiated cercariae was only slightly reduced
compared to that in wild-type (WT) controls. However, doubts
have been raised about the interpretation of data obtained
using IL-42/2 mice in several models of immunity where the
disease outcome was paradoxically unaffected by the absence
of IL-4 (31, 37, 49, 53), suggesting that another cytokine may
be involved. In this context, IL-13 has been shown to have
many overlapping functions with IL-4 (10, 67), including the
differentiation of Th2 cells (5, 36), and may thus be responsible
for the establishment of Th2-type responses in the absence of
IL-4. The similarity in the biological function of IL-4 and IL-13
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is underscored by the finding that IL-13 utilizes the a chain of
the IL-4 receptor (IL-4Ra) for signaling (22, 48). Therefore,
studies of the role of IL-4 in Th cell differentiation must take
account of the possible involvement of IL-13.
Another important concern when analyzing immune re-
sponses in intact and gene-disrupted mice is the background
strain. Indeed, in a recent study, Bancroft et al. showed that
while female IL-42/2 mice on a C57BL/6 background became
susceptible to Trichuris muris infection compared to their re-
sistant WT cohorts, IL-42/2 mice on a BALB/c background
remained resistant (6). In studies using Leishmania major,
BALB/c mice are more prone to develop Th2-type responses
than are C57BL/6 mice (54, 55), and such differences seem to
be related to differential regulation of the IL-12 receptor be-
tween mouse strains (19, 21, 58, 62). In the context of the RA
schistosome vaccine, C57BL/6 mice have been used in nearly
all studies (1–3, 12, 23, 26, 29, 40, 41, 43–45, 57, 59–61, 65, 66).
However, BALB/c mice can be protected against challenge
(reference 14 and this study), although not to the same extent
as C57BL/6 mice, and thus may be regarded as moderate and
high responders, respectively (25).
In order to reexamine the role of IL-4 (in light of the shared
IL-4–IL-13 signaling pathway) in the induction of protective
immunity to the RA schistosome vaccine, we have analyzed
various parameters of the immune response following vaccina-
tion of BALB/c mice with a genetic mutation in their IL-4Ra
gene (IL-4Ra2/2) (39). Although such mice can produce both
IL-4 and IL-13, they do not have a functioning receptor and
cannot respond to these cytokines. Our data show that, in the
absence of signaling via IL-4Ra, there is a general shift in favor
of Th1-type cell-mediated and humoral immune responses, as
judged by elevated levels of IL-12, IFN-g, and IgG2a plus
IgG2b antibodies compared to those in WT BALB/c mice.
However, contrary to our expectation, levels of protective im-
munity in vaccinated IL-4Ra2/2 mice were dramatically re-
duced. This demonstrates that signaling via the IL-4R, by IL-4
and/or IL-13, is essential for the development of high levels of
immunity. The lack of a Th2-type antibody response in these
mice (i.e., no IgG1 or IgE) could be taken as evidence that a
significant component of protective immunity induced by a
single dose of the RA vaccine in the BALB/c strain is antibody
mediated, and this is supported by the observation that serum
from vaccinated WT mice can partially restore protection in
IL-4Ra2/2 mice.
MATERIALS AND METHODS
Host and experimental protocol. Female mice (8 to 12 weeks), with a targeted
deletion of exons 7 to 9 of the IL-4Ra chain on a BALB/c background (39), were
obtained from the Max Planck Institute for Immunobiology (Frieburg, Germa-
ny). These IL-4Ra2/2 mice were subsequently bred and maintained in isolators
at the University of York animal facility, alongside WT BALB/c and C57BL/6
mice. Groups of mice were vaccinated with optimally attenuated (20-krad
gamma irradiation) cercariae of S. mansoni via the shaved abdomen (41). In
order to determine the level of protection induced, vaccinated (VC) and control
(CC) mice were challenged with 200 normal cercariae via the tail 5 weeks after
exposure to attenuated larvae. Percent protection was calculated from the mean
worm burdens of CC and VC groups 5 weeks after challenge, using the formula
(CC 2 VC)/CC 3 100.
In some experiments where study of the dermal immune response was the
objective, mice were exposed to irradiated cercariae via the pinnae. Briefly,
pinnae of anesthetized mice were immersed in 1.5 ml of cercarial suspension
contained in small rectangular glass cells (18 by 18 by 3 mm [height by depth by
width, respectively]). The number of nonpenetrant cercariae (25 to 35%) is
greater than that after exposure over the abdomen (5%), but the resultant levels
of protection are very similar.
Data comparisons were tested for significance by using Student’s t test. Arith-
metic means are shown 6 standard errors (SEM). All experiments were repeated
between two and four times.
Dermal immune responses. In order to examine immune responses at the skin
site of vaccination, two or three mice (providing four to six pinnae) were sacri-
ficed on days 2, 4, and 14 after exposure, and the extent of inflammation was
determined by measurement of the pinna thickness using a dial gauge microme-
ter (Mitutoyo). The pinnae were then cultured in vitro using a technique adapted
from that originally described by Milon and coworkers (8). Briefly, pinnae were
removed, sterilized in 70% ethanol for 5 min, and then left to air dry. The two
faces were separated using forceps and floated on 0.5 ml of RPMI medium
containing 10% fetal calf serum, 2 mM L-glutamine, 200 U of penicillin per ml,
and 100 mg of streptomycin per ml (RPMI/10) in 24-well hydrophobic culture
plates (Greiner Labortechnik, Frickenhausen, Germany), with one face per well
and the inner surface in contact with the culture medium. Pinnae were cultured
in the absence of any added parasite antigen for 18 h at 37°C with 5% CO2. The
numbers of cells detached from the dermis and free in the culture medium were
enumerated (Coulter Z1; Coulter, Luton, United Kingdom). The culture super-
natant was collected and stored at 220°C for subsequent cytokine analysis. In all
experiments, tissues from naive WT and IL-4Ra2/2 mice were similarly pre-
pared to establish baseline levels for dermal immune responses.
Lymphocyte assays. In order to measure lymphocyte activity during priming,
axillary lymph nodes (LN) were removed from mice on days 5 and 15 postvac-
cination when the response is at peak levels (41). The LN cells (2 3 105
cells/well) were cultured in the presence or absence of schistosome antigen from
lung-stage larvae (soluble lung-stage antigen preparation [SLAP]) (45) at 50
mg/ml or concanavalin A at 1 mg/ml. CD41 lymphocytes were isolated from
pooled LN cells following labeling with anti-CD41 magnetic beads and separa-
tion on VS1 MACS columns (Miltenyi Biotech, Hamburg, Germany). Eluted
purified CD41 lymphocytes were cultured at 105 cells/well together with 2 3 105
naive splenocytes irradiated with 3,000 rads as feeder cells. At 72 h, supernatants
were removed from the LN and CD41 cell cultures for detection of various
cytokines, and lymphocyte proliferation was measured by the uptake of [3H]thy-
midine (18.5 kBq/well; ICN Biomedicals, Thame, Oxon, United Kingdom) into
cellular DNA following a further 18-h in vitro culture.
Cytokine ELISAs. Cytokine-specific double-antibody enzyme-linked immu-
nosorbent assays (ELISAs) were used to measure the amounts of IL-4, IL-5, and
IL-10 present in the culture supernatants (40, 41, 60). ELISAs were also per-
formed to measure IFN-g using the R4-6A2 MAb paired with biotinylated
XMG1.2 MAb and IL-12p40 using the C15.6 MAb paired with the biotinylated
C17.8 MAb (all from Pharmingen). Recombinant IFN-g obtained from the 211A
CHO cell line (60) and recombinant IL-12 (gift of S. Wolf, Genetics Institute,
Cambridge, Mass.) were used as internal standards. IL-13 was measured using a
specific Quantikine kit (R & D Systems, Abingdon, United Kingdom). The lower
limits to detection were 25 (IFN-g), 20 (IL-12p40), and 10 (IL-4, IL-5, IL-10, and
IL-13) pg/ml.
Analysis of pulmonary immune responses. On day 14 postchallenge, at the
peak of the pulmonary immune response, leukocytes were recovered from the
airways by bronchoalveolar lavage (BAL) as described previously (1, 3). The
proportions of the major leukocyte classes within each BAL sample were deter-
mined, based on relative size and granularity, using a Coulter XL flow cytometer.
BAL cells (2 3 105 cells/well) were cultured in 96-well plates in the presence and
absence of SLAP, and supernatants were removed at 48 and 72 h for cytokine
measurement. Lobes of lung tissue were taken from individual mice after lavage
and fixed in 4% formal saline. Tissue was paraffin embedded, serially sectioned
at 7 mm, and stained with Mayer’s hemalum-eosin (BDH Laboratory Supplies,
Poole, United Kingdom).
Antibody analysis. Serum samples were collected from vaccinated IL-4Ra2/2
and WT mice just prior to challenge infection at 5 weeks and before perfusion at
10 weeks. The relative levels of SLAP-specific antibody isotypes in the sera were
determined by ELISA over a series of doubling dilutions using horseradish
peroxidase-conjugated antibodies (IgG, IgG1, IgG2a, and IgG2b; Zymed Labs,
Inc., South San Francisco, Calif.) as described in detail previously (44). Total
serum IgE was determined by capture ELISA, and binding levels were compared
relative to a standard curve of recombinant IgE (40).
Passive transfer of antisera. Pooled sera from groups of 20 to 30 WT and
IL-4Ra2/2 mice were obtained 5 weeks after vaccination with 500 irradiated
cercariae and frozen prior to use. On day 0, 150 ml of serum from either
vaccinated WT or IL-4Ra2/2 donor mice was administered intravenously (tail
vein) to two separate groups of naive IL-4Ra2/2 mice (n 5 5). Four hours later,
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these recipient mice were exposed to 200 normal cercariae via the abdominal
skin. On days 3, 7, and 10, repeat doses of sera (150 ml) were administered to the
two recipient groups, via the same route. On day 35, the level of resistance was
calculated from the mean challenge worm burdens of mice receiving WT serum,
compared to those in mice receiving IL-4Ra2/2 serum (see above for calcula-
tion). IL-4Ra2/2 mice which were exposed to 200 cercariae but received no sera
served as a further control group.
RESULTS
High levels of protective immunity are induced in WT but
not IL-4Ra2/2 mice. In order to assess the effect of the IL-4R
deficiency on the ability of the host to make a protective im-
mune response, groups of naive and vaccinated, WT and IL-
4Ra2/2, mice were exposed to a challenge of normal larvae 5
weeks after vaccination. The numbers of challenge worms re-
covered from control WT and IL-4Ra2/2 mice were not sig-
nificantly different from each other (P . 0.05) in either of the
two experiments, showing that the disruption to the IL-4Ra
signaling pathway had no effect on the maturation of a primary
worm burden (Fig. 1a and b). However, while vaccinated WT
(BALB/c) mice had significantly lower challenge worm bur-
dens (experiment 1, 54.6%, and experiment 2, 59.4%) than
their respective challenge control groups (P , 0.001), vacci-
nated IL-4Ra2/2 mice had only slightly lower worm burdens
(experiment 1, 28.3%, and experiment 2, 18.7%) which were
not significantly different from their challenge control cohorts
(P . 0.05). It appeared, therefore, that the RA vaccine was
incapable of inducing significant levels of protective immunity
in IL-4Ra2/2 mice. A high level of protection was obtained in
C57BL/6 mice (63.6%; experiment 1, data not shown) and
confirms previous data from our laboratory and others that this
strain of mouse is a high responder to the RA vaccine, com-
pared with the BALB/c strain, which is regarded as only a
moderate responder (25).
The production of IL-12p40 by dermal cells is elevated in
IL-4Ra2/2 mice. The skin site of exposure (pinnae) was ex-
amined in order to determine any changes, caused by the lack
of IL-4R signaling, in the innate immune response following
exposure to RA cercariae. A significant inflammatory response
was recorded as early as day 2, when the thickness of the
pinnae had increased in both IL-4Ra2/2 (P , 0.01) and WT
(P , 0.001) mice, compared to groups of naive IL-4Ra2/2 and
WT animals, respectively (Fig. 2a). The skin remained in-
flamed for at least the next 12 days, but there was no significant
difference in pinna thickness between the two groups at any
time point. As a crude measure of the overall cellularity of the
pinnae, the number of leukocytes collected in the supernatant
after 18 h of in vitro culture was determined (Fig. 2b). There
FIG. 1. Worm burdens of challenge control (open bars) and vacci-
nated and challenged (black bars) mice 5 weeks after challenge infec-
tion with 200 normal cercariae in two different experiments. Bars are
the means of individual mice (n 5 5 to 7) 1 SEM in each group.
Significance values represent differences in worm burdens between
vaccinated mice and the relevant control group (ppp, P ,0.001; N.S., P
.0.05). FIG. 2. Dermal immune responses in vaccinated WT (hatched
bars) and IL-4Ra2/2 (black bars) mice at days 0 (naive), 2, 4, and 14
after vaccination showing pinna thickness (a), recovered cell number
(b), and secretion of IL-12p40 (c) by in vitro-cultured pinnae in the
absence of added antigen. Bars are the means of results obtained from
individual pinnae (n 5 6) 1 SEM.
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was a rapid increase in the numbers of cells recovered from
WT and IL-4Ra2/2 mice, and although these had declined by
day 14, they were still significantly above naive mouse values
(P , 0.01). There was, however, no significant difference be-
tween the two groups at any time point.
The supernatants obtained following in vitro culture of the
split pinnae were assayed for the presence of IL-12p40 as a
relative measure of biologically active IL-12p70. A novel find-
ing of our study was that vaccinating parasites are indeed
potent stimulators of IL-12 production in the first few days
after immunization. An increase in protein secretion was de-
tected by day 2, compared to the day 0 (naive) time point, in
both WT and IL-4Ra2/2 groups (Fig. 2c). Moreover, secretion
of abundant IL-12 was still evident by day 14, reflecting the
persistence of RA larvae in the skin (43). Another important
observation was that secretion of IL-12p40 by cells in the
dermal tissues of IL-4Ra2/2 mice was elevated compared to
the level from WT mice. The difference was most pronounced
on day 2 (P , 0.05), when the quantity of IL-12p40 was nearly
double the value in WT mice.
Th2- but not Th1-associated cytokine production in the
skin-draining LN after vaccination is altered in the absence of
IL-4Ra2/2. In order to determine the effect on the develop-
ment of Th lymphocyte subsets in the absence of IL-4 signal-
ing, we measured the cytokine production of cells obtained
from the skin-draining LN cultured in vitro with SLAP. At day
5 and day 15, cells from both IL-4Ra2/2 and WT mice se-
creted abundant IFN-g, the levels of which were not signifi-
cantly different from each other (P . 0.01) (Fig. 3a). Elevated
levels of IL-4 were also detected in the two groups of vacci-
nated mice, and these were very similar at both time points
(P . 0.05) (Fig. 3b). In sharp contrast, the production of IL-13
was much lower in vaccinated IL-4Ra2/2 mice at day 5 and day
15 than in WT mice (P , 0.05) (Fig. 3c), although the levels in
both groups were lower at the later time point. A similar
pattern of secretion was observed for IL-5, where much higher
levels were detected in WT than in IL-4Ra2/2 mice on day 5
(P , 0.001) (Fig. 3d). By day 15, very little IL-5 was detected
in either group of mice. Finally, it was observed that, although
the levels of IL-10 were lower in IL-4Ra2/2 than in WT mice
at day 5 (Fig. 3e), the pattern was reversed at day 15, with cells
from IL-4Ra2/2 mice secreting more IL-10 than their WT
counterparts (P , 0.05). Experiments using purified CD41
lymphocytes from pooled LN cells confirmed that virtually all
(.95%) of the cytokine production (for all five cytokines
tested) was attributable to Th cells (data not shown). Thus, at
day 5 postvaccination when the production of IL-5 and IL-13
was most vigorous, there was a decrease in the production of
FIG. 3. Secretion of IFN-g (a), IL-4 (b), IL-13 (c), IL-5 (d), and
IL-10 (e) by LN cells obtained on days 5 and 15 postvaccination and
stimulated for 72 h with SLAP. Bars are means of individual (n 5 3 or
4) WT (hatched) and IL-4Ra2/2 (black) mice 1 SEM. Cytokine pro-
duction was measured by specific ELISAs. Open bars represent cyto-
kine production in the absence of added antigen.
TABLE 1. Immune responses in the lungs of vaccinated mice 14 days after challenge infectiona
Type of data WT IL-4Ra2/2 p value
BAL cell population (105)
Total 13.86 6 1.13 14.58 6 1.46 NS
Macrophages 9.38 6 0.71 10.0 6 0.91 NS
Granulocytes 0.69 6 0.18 0.46 6 0.07 NS
Lymphocytes 2.55 6 0.22 3.97 6 0.93 NS
In vitro cytokine production (pg/ml)
IFN-g 543.7 6 74.7 1,612.2 6 65.2 ,0.05
IL-4 71.0 6 7.5 120.2 6 3.0 ,0.01
IL-5 49.5 6 28.6 0.0 6 0.0 NS
IL-13 397.0 6 133.8 523.7 6 102.4 NS
a Cells were recovered from the lungs by BAL 14 days after challenge infection at 5 weeks postvaccination. Data are means for five individual mice in each group 6
SEM. Cell types were distinguished on the basis of their size and granularity by flow cytometry. Cytokines were measured by ELISA in supernatants following 72 h of
in vitro culture of BAL cells in the presence of SLAP. No cytokines were detected in the absence of added antigen (data not shown). NS, not significant.
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these Th2-type cytokines in IL-4Ra2/2 mice. Nevertheless,
there was no difference in the production of the other arche-
typal Th2 cytokine IL-4, and there was no corresponding in-
crease in the production of the Th1 cytokine IFN-g.
Pulmonary effector responses after challenge are not sub-
stantially different in IL-4Ra2/2 mice. It has been shown pre-
viously that protective immunity induced by a single dose of
the RA vaccine is associated with a Th1-mediated inflamma-
tory response in the lungs and that this is the main site for
challenge parasite elimination in C57BL/6 mice (reviewed in
reference 11). Consequently, we examined the immune re-
sponses in the pulmonary tissues in vaccinated mice 2 weeks
after challenge infection, at the peak of inflammation. The
response in the lungs at this time is conventionally associated
with a large increase in the number of cells recoverable by
BAL, comprising macrophages, granulocytes, and lymphocytes
identified on the basis of their size and granularity (60). In the
current study, using mice on a BALB/c background, we recov-
ered each of these cell types in numbers similar to those pre-
viously reported for intact vaccinated C57BL/6 mice (3), with
the major cell population being macrophages (Table 1). Large
numbers of infiltrating lymphocytes were also recovered, but
there was no statistical difference in the number of any cell
type recovered from IL-4Ra2/2 compared to that from WT
mice.
In order to determine whether the IL-4R deficiency had an
effect upon the profile of cytokine production by the BAL cell
population, we measured the quantities of IFN-g, IL-4, IL-5,
and IL-13 secreted after stimulation in vitro with SLAP for
72 h (Table 1). The most abundant cytokine was IFN-g, with
significantly higher levels detected in cultures from IL-4Ra2/2
than from WT mice (P , 0.05), suggesting a shift to a more
polarized Th1 response. There was also an increase in the
production of IL-4 and IL-13 in the IL-4Ra2/2 group, dem-
onstrating that Th2 responses can evolve in the absence of
IL-4R-mediated signaling. In contrast, there was no IL-5 in
cultures from IL-4Ra2/2 mice, although only low levels of IL-5
were detected in some WT mice.
Since we had detected few differences between the immune
responses of IL-4Ra2/2 and WT mice, we examined the pul-
monary inflammatory lesions which form around the challenge
larvae, by light microscopy. The number of foci in sections of
lungs from the two groups was similar, as were their size and
cellular composition (data not shown). In both groups, the
cellular infiltrate was largely mononuclear, with few eosino-
phils or neutrophils in WT mice and almost none in IL-4Ra2/2
mice. This contrasts with the Th2-polarized pulmonary re-
sponse in vaccinated IL-12p402/2 (C57BL/6 strain) (3) and
IFN-gR2/2 (129 strain) (64) mice, where distinct eosinophilia
was detected.
IgG2a and IgG2b production is elevated but IgG1 and IgE
levels are reduced in IL-4Ra2/2 mice. In addition to measur-
ing parameters of the cell-mediated immune response, we as-
sayed humoral responses in serum samples taken at week 5
(just prior to challenge infection when the immune response
should be fully established) and at week 10 (just prior to
hepatic perfusion and determination of protection) for differ-
ences in the relative levels of antibody isotypes. Anti-SLAP
IgG levels were similar in IL-4Ra2/2 and WT mice, with the
levels in both groups increasing from week 0 (naive) through
week 5 to week 10 (Fig. 4). However, IgG isotypes were dra-
matically different. In WT mice, the levels of antigen-specific
IgG2a and IgG2b, both associated with Th1-type immune re-
sponses, at weeks 5 and 10 were only marginally higher than at
time zero, whereas in IL-4Ra2/2 mice the levels of these two
isotypes were markedly elevated and significantly higher than
in WT mice (P , 0.05, week 5; P , 0.001, week 10) as expected
from the shift to Th1 cytokine production observed for IL-
4Ra2/2 mice. In contrast, IL-4Ra2/2 mice mounted a negli-
gible antigen-specific IgG1 antibody response compared to
WT animals, in which the levels of IgG1 were significantly
higher (P , 0.001) at both time points. IgE was barely detect-
able in IL-4Ra2/2 mice, while in WT mice, over 4,000 and
9,000 pg/ml were present at weeks 5 and 10, respectively. Con-
sequently, IL-4Ra2/2 mice had a severe deficiency in their
ability to make antibodies associated with Th2-type responses
which was compensated for by an increase in the levels of IgG2
subclasses.
Passive transfer of vaccine sera from WT to IL-4Ra2/2 mice
restores partial protection against challenge infection. Since
the absence of IgG1 and IgE antibodies in the serum of IL-
4Ra2/2 mice appeared to be associated with the lack of pro-
tective immunity, we attempted to investigate whether protec-
FIG. 4. Antibody production in WT (hatched bars) and IL-4Ra2/2
(black bars) mice at week 0 (naive) and at weeks 5 and 10. Levels of
SLAP-specific IgG, IgG1, IgG2a, and IgG2b were detected by ELISA,
and results are shown at a 1/300 serum dilution. Total serum IgE was
calculated from a recombinant standard curve (lower detection limit,
200 pg/ml). Bars are means of individual mice (n 5 6 or 7) 1
SEM. O.D., optical density.
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tion could be transferred to IL-4Ra2/2 mice using serum
obtained from WT (BALB/c) mice 5 weeks after vaccination.
Conventionally, immunized mice are exposed to challenge lar-
vae at this time point, and so would expect the appropriate
effector responses to be fully established 5 weeks after vacci-
nation. Serum from vaccinated WT and IL-4Ra2/2 mice,
which had equivalent levels of antigen-specific total IgG anti-
bodies (Fig. 4), was administered to different groups of naive
IL-4Ra2/2 mice over the period when elimination of migrating
larvae is likely to occur. In this respect, IL-4Ra2/2 mice re-
ceiving vaccine serum from WT mice were protected by 25.9%
(P , 0.01) and 20.5% (P , 0.05) compared with IL-4Ra2/2
mice receiving vaccine serum from IL-4Ra2/2 mice (Table 2).
Moreover, sera from vaccinated IL-4Ra2/2 mice conferred no
protection since recipient IL-4Ra2/2 mice had worm burdens
similar to those of IL-4Ra2/2 mice which had not received any
sera (106.2 6 5.5 compared with 97.7 6 6.2; P . 0.05).
DISCUSSION
The established dogma that protective immunity to a single
dose of the RA schistosome vaccine in C57BL/6 mice is asso-
ciated with a strong Th1 cell-mediated immune response in-
volving an inflammatory reaction to challenge parasites in the
lungs has been supported in many studies using cytokine ab-
lation treatments (57, 59) or cytokine-deficient mice (1, 23, 64).
Therefore, we predicted that in the absence of IL-4R signaling,
Th1-type responses would increase and that consequently pro-
tective immunity would be greater in IL-4Ra2/2 than in WT
mice. In addition, since our studies were performed using mice
on a BALB/c genetic background, which develop only moder-
ate levels of protection compared to the more Th1-polarized
C57BL/6 strain mice (25), any shift toward a Th1 phenotype
would be expected to lead to greater levels of protection.
Instead, we found that IL-4Ra2/2 mice developed no signifi-
cant protection. These results are in striking contrast to those
in studies using IL-42/2 mice on a C57BL/6 background, in
which high levels of protective immunity were induced (23, 29).
Since our findings were not as predicted, we sought to iden-
tify differences in the immune responses shortly after vaccina-
tion which might provide an explanation for the abrogation of
protection in IL-4Ra2/2 mice. The production of IL-12 by
accessory cells of the innate response is a key feature for the
successful induction of Th1-type immune responses (1, 32, 35),
whereas both IL-4 and IL-13 are effective inhibitors of IL-12
production (13, 47, 62). In this context, our data demonstrate
that, in the absence of IL-4R signaling, IL-12p40 production
was significantly increased in the skin during the first 2 weeks
after vaccination when priming of the acquired immune re-
sponse is passing through a critical phase. It also extends the
observations of Noben-Trauth et al. (50), who recorded a two-
fold-elevated expression of IL-12p40 mRNA in the LN of
IL-4Ra2/2 mice exposed to L. major. Therefore, our data
show that IL-4R signaling has an important influence on the
cutaneous innate immune response to schistosomes, and it may
be envisaged that higher levels of IL-12 in IL-4Ra2/2 mice
would drive the acquired Th lymphocyte response toward the
Th1 phenotype.
In spite of the increased IL-12 production in IL-4Ra2/2
mice, the levels of IFN-g secreted at early time points by LN
cells cultured in vitro with schistosome antigen were no higher
than in WT mice. A similar failure to observe increased IFN-g
production in the absence of IL-4R signaling has been re-
ported in other models of infection (7, 38, 50, 51). One possible
explanation is that the production of IL-12 in WT mice is
sufficient to induce a maximal IFN-g response and that the
increased levels in the IL-4Ra2/2 mice are superfluous. A
more likely explanation is that IL-12R b2 expression is not
increased in the IL-4Ra2/2 mice on a BALB/c background,
which restricts signaling by IL-12. Indeed, Mohrs et al. (38)
recently found that IL-4Ra2/2 mice exposed to L. major had
levels of IL-12R b2 mRNA which were indistinguishable from
those of their WT BALB/c cohorts but much lower than those
of C57BL/6 mice, thus confirming that genetic background
determines maintenance of IL-12 signaling (21, 58) and that
this is independent of signaling via IL-4 (19).
Nevertheless, at later stages, when the immune effector
mechanisms have become established, we observed a nearly
threefold increase in IFN-g production by BAL cells. Although
not addressed in this paper, it is possible that other cytokines
(e.g., tumor necrosis factor a and IL-1a) rescue the expression
TABLE 2. Reduced worm burdens in IL-4Ra2/2 mice after passive transfer of serum from vaccinated WT micea
Expt and type of data
Data for group:
Group 1
(no serum administration)
Group 2
(administration of IL-4Ra2/2 serum)
Group 3
(administration of WT serum)
Expt 1
Mean worm burden 6 SEM 97.7 6 6.2 106.2 6 5.5 78.6 6 2.3
% Reduction compared with group 1 8.7 19.5
P value compared with group 1 .0.05 ,0.05
% Reduction compared with group 2 25.9
P value compared with group 2 ,0.01
Expt 2
Mean worm burden 6 SEM 73.8 6 6.1 58.6 6 3.1
% Reduction compared with group 2 20.5
P value compared with group 2 ,0.05
a Shown are worm burdens in IL-4Ra2/2 mice treated with vaccination serum 5 weeks after challenge with 200 normal cercariae in two different experiments. Serum
from IL-4Ra2/2 or WT mice exposed to a single dose of irradiated cercariae was delivered by an intravenous route in aliquots of 150 ml on days 0, 3, 7, and 10 after
challenge infection. Mean worm burdens are for individual mice (n 5 5). Significance values represent the differences in the worm burdens between mice receiving
serum from WT mice and groups receiving serum from IL-4Ra2/2 mice or no serum.
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of IL-12R b2 subunit at later times postvaccination and allow
a more Th1-biased response to evolve (58). While the increase
in IFN-g was significant, the levels in IL-4Ra2/2 mice did not
reach those in BAL cell cultures taken from vaccinated and
challenged C57BL/6 WT mice, where between 5 and 10 ng/ml
is routinely detected at the same time point (e.g., see refer-
ences 1 and 3). The increased level of IFN-g in vaccinated
IL-4Ra2/2 mice is likely to be the major factor favoring the
antibody switch to the IgG2a and IgG2b subclasses, also ob-
served in other experimental systems in the absence of IL-4Ra
(9, 27, 38, 39, 63). Taken together, our studies show that the
lack of effective signaling by IL-4 and/or IL-13 caused a signif-
icant shift in the phenotype of the ensuing immune response
toward the Th1 phenotype, as judged by cytokine secretion in
the lungs and the profile of antibody isotypes.
As a corollary to the increase in Th1 responses, it might be
expected that Th2-type responses would be decreased or even
abolished in IL-4Ra2/2 mice. Indeed, the production of both
IL-5 and IL-13 was lower in IL-4Ra2/2 mice than in their WT
cohorts, and the production of IgE remained below the level of
detection (,200 pg/ml) in the former group. We conclude that
both IgE and IL-5 are dependent upon IL-4R, although in
certain situations IL-5 production can occur in the absence of
IL-4Ra (9). Moreover, the absence of significant levels of
antigen-specific IgG1 at week 5 is probably due to the failure of
IL-4Ra2/2 mice to recognize IL-4 rather than IL-13, since
IL-132/2 mice mount highly elevated or normal levels of IgG1
(5, 36). Nevertheless, a newly described IL-12-induced switch
to IgG1 (18) may result in the low levels of IgG1 detected at
week 10 in IL-4Ra2/2 mice. Although the majority of Th2-
type immune responses were reduced in IL-4Ra2/2 mice, the
production of IL-4 by the cells in the draining LN was no lower
than that in their WT counterparts. This leads us to conclude
that a low level of IL-4 production continued in IL-4Ra2/2
mice and that, in the absence of its receptor, free IL-4 accu-
mulated in the culture supernatant for subsequent detection by
ELISA. This is also probably the cause of the apparent signif-
icant increase in the release of IL-4 (and IL-13) by cultured
BAL cells from vaccinated IL-4Ra2/2 mice.
These results demonstrate that the production of Th2-asso-
ciated cytokines can occur independently of IL-4 and IL-13, as
postulated in earlier studies using Leishmania infection (38)
and alum as an adjuvant (9), and suggests that alternative
factors are responsible for Th2 differentiation. However, it is
possible that the residual levels of IL-13 are responsible by
signaling via IL-13Ra2 which binds IL-13 independently of the
IL-4Ra chain (17), although this has not been identified for
IL-4Ra2/2 mice so far. Although studies, other than ours,
have reported a more substantive effect of IL-4R signaling on
the amounts of Th2 cytokines, these have been performed
under conditions of extreme Th2 polarization following egg
deposition in schistosome-infected mice (27, 28) or infection
with a gut nematode, Nipostrongylus brasiliensis (7). In contrast,
the RA vaccine model in our studies provides a situation with
a more limited antigen load which is predisposed to induce a
Th1 response and therefore does not amplify the defect in the
production of Th2 cytokines.
In seeking to identify the mechanism responsible for the
failure to achieve a high level of protection in IL-4Ra2/2 mice,
we examined the inflammatory foci in the lungs which are
thought to be responsible for challenge parasite elimination in
vaccinated mice (12). Despite the changes in cytokine produc-
tion observed for cultures of BAL cells from vaccinated IL-
4Ra2/2 mice compared to WT mice, we could not see any
major differences in pulmonary foci. This contrasts with studies
of allergic asthma were dominant Th2-type responses such as
eosinophilia, airway hyperresponsiveness, and mucus produc-
tion were extremely reduced in IL-4Ra2/2 mice (20) and stud-
ies in schistosome-infected IL-4Ra2/2 mice where Th2-type
inflammatory granulomas failed to form around eggs in the
liver (27). In the present study, it appears that the pulmonary
foci in vaccinated IL-4Ra2/2 mice remained polarized to the
Th1 type but were ineffective at stopping challenge parasites.
This is similar to vaccinated TNFRI2/2 mice, where the Th1-
type pulmonary immune response was not substantially differ-
ent from that in WT C57BL/6 cohorts but the mice failed to
develop protective immunity to the RA vaccine (61). Subtle
differences in the complexion of pulmonary foci in vaccinated
IL-4Ra2/2 mice, which are currently beyond our methods of
detection, may explain the failure to eliminate challenge par-
asites.
The one immunological parameter which did appear to cor-
relate with the failure to induce protection in IL-4Ra2/2 mice
was the absence of IgG1 and IgE antibodies at the time of
challenge. However, since administration of anti-IFN-g anti-
bodies to vaccinated mice led to greater than 90% abrogation
of protection (59), it was previously presumed that there was
little scope for a protective role for antibodies after a single
vaccination. In addition, studies using gene-disrupted mice ex-
posed to the RA vaccine showed that IgE (30), signaling via the
FcR g chain (26), or antibodies in general (2) were not re-
quired for protection. On the other hand, another study pro-
posed a limited role for antibodies by showing that protection
was not fully abrogated in vaccinated mMT mice (26). Conse-
quently, we sought to determine a role in protection for anti-
bodies by passively transferring serum from vaccinated WT or
IL-4Ra2/2 mice to naive IL-4Ra2/2 mice and assessing its
effect on the maturation of challenge larvae. Since serum from
vaccinated WT mice was largely composed of the IgG1 class,
while that from the vaccinated IL-4Ra2/2 mice contained only
IgG2a and IgG2b but little IgG1, we could compare the rela-
tive protective capacities of these different isotypes without
further purification procedures. The failure to transfer resis-
tance using serum from IL-4Ra2/2 mice demonstrates that
IgG2a and IgG2b antibody classes are not important effectors
of antischistosome immunity. However, the partial reduction
in worm burden in mice receiving serum from WT mice ex-
posed to a single dose of the RA vaccine indicates that serum
which is rich in IgG1 and IgE does have a role in protection. In
this context, previous studies have shown that the protective
capacity of serum from multiply vaccinated mice, where pro-
tection is mediated by antibodies (2, 23, 26), is associated with
the IgG fraction (33) and more specifically the IgG1 subclass
(16). Given that very large numbers of mice would be required
to provide sufficient donor sera to permit fractionation into the
IgG1 and IgE components, we consider it ethically unaccept-
able to formally prove that the protective capacity of the trans-
ferred sera lies with the IgG1 subclass. However, we believe it
is unlikely that IgE has a protective role since vaccinated
IgE2/2 mice remain fully protected (30). In addition, IgE-
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dependent responses mediated by mouse eosinophils cannot
occur since the low-affinity IgE receptor Fc-eRII is not present
on these cells (15).
Our inability to transfer maximal levels of protection (i.e., 55
to 60% observed in WT mice) using serum from singly vacci-
nated WT mice may arise from administration of insufficient
quantities of antibodies, despite serum being given via an in-
travenous route. Clearly, it is difficult to replicate in IL-4Ra2/2
mice the supply of antibodies produced continuously in intact
WT mice. Alternatively, we might conclude that protection in
WT mice of a BALB/c background, exposed to a single vacci-
nation, is comprised of both antibody- and IFN-g-mediated
effector mechanisms. In this context, the low levels of protec-
tion (albeit not significant) seen for IL-4Ra2/2 mice after
percutaneous vaccination may be due to a residual IFN-g-
mediated component. On the other hand, protection in
C57BL/6 mice appears to be more dependent upon IFN-g
(59), while vaccinated IL-42/2 mice on a C57BL/6 background,
which also fail to produce IgG1 antibodies, have high levels of
IFN-g and retain their ability to mount high levels of protective
immunity (23). Finally, it is possible that IL-13 alone is playing
an important role in protection induced by the RA vaccine by
a new but, as yet, undefined mechanism as revealed in studies
of Trichuris (4, 6), or Leishmania (34, 39).
In conclusion, the absence of IL-4R signaling has important
effects on both the innate and acquired immune responses
induced by the RA schistosome vaccine in BALB/c mice, which
result in a failure to establish a protective response. The in-
ability to produce sufficient IgG1 antibodies provides the most
likely explanation for the lack of protection in IL-4Ra2/2
mice. However, until IL-4Ra2/2 mice on a C57BL/6 back-
ground become available, it is difficult to establish fully the role
that host strain plays in controlling the effects observed in this
study. Moreover, comparative studies of the efficacy of the RA
vaccine in mice deficient for IL-4, IL-13, and IL-4–IL-13 in
combination would be instrumental in dissecting the roles of
these two important cytokines and may reveal an unappreci-
ated role for IL-13.
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